The Contradictions of the State Policy on Regulation of Prices on Medicines: Problems and Ways of Their Solving
The article analyzes the existing model of regulation of prices on medicines in the Russian Federation. Problems of this model are described (especially the fact that it stimulates elimination of cheaper medicines from the product range of pharmacies and pharmaceutical distributors and hinders investments into local development of innovative medicines). Ways to solve these problems are proposed. It is demonstrated that all medicines should be divided into three groups according to their price, and for each group a special method of price regulation should be used. It is also proposed to implement a guaranteed level of profitability of local developers of innovative medicines.
To our knowledge, this item is not available for
download. To find whether it is available, there are three
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a search for a similarly titled item that would be available.
When requesting a correction, please mention this item's handle: RePEc:nos:voprec:2011-10-9. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Sergei Parinov)
If references are entirely missing, you can add them using this form.